Clinical implications of six-minute walk test in patients with idiopathic pulmonary fibrosis: a retrospective cohort study
Therapeutic Advances in Respiratory Disease · 2024
DOI: 10.1177/17534666241275329 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Therapeutic Advances in Respiratory Disease, 2024. Verfasst von Min Jee Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Exercise Tolerance, Idiopathic Pulmonary Fibrosis, Walk Test. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Asan Institute for Life Sciences, Asan Medical Center.
Abstract (Originalsprache)
Background
A six-minute walk test (6MWT) is a reproducible, easily performed test, and is widely used to determine functional exercise capacity in patients with idiopathic pulmonary fibrosis (IPF). However, there is currently a paucity of data on the clinical significance of baseline and serial 6-minute walk tests in patients with IPF, especially in Asian patients.
Objectives
We aimed to investigate the clinical significance of serial 6MWT in patients with IPF, especially in Asian patients.
Design
This is a single-center retrospective cohort study.
Methods
Clinical data of patients diagnosed with IPF at a tertiary center in Korea were retrospectively analyzed. IPF diagnosis was defined according to the clinical guidelines of the American Thoracic Society (ATS)/European Respiratory Society (ERS)/Japanese Respiratory Society/Latin American Thoracic Association.
Results
There were 216 patients diagnosed with IPF from December 2012 to January 2022, of whom 198 had a baseline of 6MWT data. The mean age of the cohort was 66.9 ± 8.6, and 89% were male. The non-survivors showed significantly lower six-minute walk distance (6MWD), minimum saturation of peripheral oxygen (SpO 2 ) during 6MWT, forced vital capacity, and diffusing capacity of the lung for carbon monoxide than survivors at baseline. A multivariate Cox analysis demonstrated that lower minimum SpO 2 was independently associated with increased mortality rates (Hazard ratio (HR): 1.081, 95% confidence interval (CI): 1.024–1.142, p = 0.005). Higher mortality rates were also associated with echocardiographic-determined pulmonary hypertension (HR: 2.466, 95% CI: 1.149–5.296, p = 0.021) at diagnosis. Among 144 patients with 6MWT results at 12 months, patients with a decline of 50 m or more in the 6MWD showed poorer overall survival than others (median survival: 45.0 months vs 58.0 months, p < 0.001).
Conclusions
Baseline lower minimum SpO 2 during 6MWT was an independent prognostic factor in patients with IPF, and a decline in 6MWD in serial follow-up was also associated with a poorer prognosis. These findings suggest that both baseline 6MWT and follow-up data are important in the prognostication of patients with IPF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Advanced Lung Disease and Transplant Program, Inova Heart and Vascular Institute, Inova Fairfax Hospital, Falls Church, VA, USA.
- Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea.
ORCID-Profile: Min Jee Kim, Steven D Nathan, Ho Cheol Kim
Förderung
- National Research Foundation of Korea
- Asan Institute for Life Sciences, Asan Medical Center
Zitieren
APA
Kim, M. J., Nathan, S. D., Kim, H. H., & Kim, H. C. (2024). Clinical implications of six-minute walk test in patients with idiopathic pulmonary fibrosis: a retrospective cohort study. Therapeutic Advances in Respiratory Disease. https://doi.org/10.1177/17534666241275329
Vancouver
Kim MJ, Nathan SD, Kim HH, Kim HC. Clinical implications of six-minute walk test in patients with idiopathic pulmonary fibrosis: a retrospective cohort study. Therapeutic Advances in Respiratory Disease. 2024. doi:10.1177/17534666241275329
BibTeX
@article{Kim2024,
author = {Kim, Min Jee and Nathan, Steven D and Kim, Hyeon Hwa and Kim, Ho Cheol},
title = {Clinical implications of six-minute walk test in patients with idiopathic pulmonary fibrosis: a retrospective cohort study},
journal = {Therapeutic Advances in Respiratory Disease},
year = {2024},
doi = {10.1177/17534666241275329}
}
EUVIMED